<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02554864</url>
  </required_header>
  <id_info>
    <org_study_id>2015-0046-B</org_study_id>
    <nct_id>NCT02554864</nct_id>
  </id_info>
  <brief_title>Location of Injection of Local Anesthetics in the Adductor Canal Block</brief_title>
  <acronym>LILAC</acronym>
  <official_title>Location of Injection of Local Anesthetics in the Adductor Canal Block: A Randomized Controlled Trial of the Effect on Postoperative Analgesia and Motor Power</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Women's College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Women's College Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The adductor canal block (ACB) is the standard of care for analgesia after Anterior Cruciate
      Ligament (ACL) repair. ACB is performed by injecting local anesthetic (freezing) in the
      subsartorial canal in the thigh which is about 7-10cm long. Preliminary evidence suggests
      that different injection sites within the canal may produce different degrees of analgesia
      and quadriceps motor block. This trial seeks to determine the effects of various ACB
      injection sites on postoperative analgesia and motor power following ACL repair.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adductor canal block (ACB) is replacing femoral nerve block (FNB) as the peripheral nerve
      block of choice for knee surgery. The ACB aims to inject local anesthetics (LA) within the
      neurovascular sheath in the subsartorial adductor canal around the femoral nerve. The point
      where the sartorius muscle crosses over the femoral artery is generally the accepted site for
      performing ACB. Clinically, injecting LA in the adductor canal blocks the sensory innervation
      of the knee and thus offers pain relief that is similar to FNB while conserving motor power
      around the knee. While these benefits are desirable, the exact location for performing ACB
      that ensures these benefits, remains debatable. The subsartorial adductor canal itself is
      7-10cm long and the anatomical location of the sensory and motor nerves that innervate the
      knee and its surrounding muscles in this canal may vary. This randomized controlled trial is
      designed to identify and refine the ACB technique by clinically determining the effects of
      various ACB injection locations on postoperative analgesia and quadriceps motor power
      following ACL repair.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 22, 2016</start_date>
  <completion_date type="Actual">January 2, 2018</completion_date>
  <primary_completion_date type="Actual">December 15, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative 24 Hour Oral Morphine Equivalent Consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>Post-Operative Analgesia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Motor Power - Peak Force as measured by a dynamometer</measure>
    <time_frame>30 Minutes post Block</time_frame>
    <description>Percentage decrease in quadriceps motor strength at 30 minutes following adductor canal block compare to baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid Consumption</measure>
    <time_frame>During surgical procedure</time_frame>
    <description>Intra-operative opioid consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total opioids in Post Anesthetics (PAC)</measure>
    <time_frame>Total length of time in PACU (total time in minutes from arrival in PACU to discharge to the Surgical Day Care is between 60-180 minutes</time_frame>
    <description>Cumulative oral morphine equivalent consumption in PACU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Scores - Questionnaire</measure>
    <time_frame>24 hours post block</time_frame>
    <description>Area under the curve for rest pain scores plotted against time during the first 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Recovery (QoR-15)</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Quality of recovery measured using the QoR-15 at 24 hours postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction - Questionnaire</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Patient satisfaction with analgesia - NRS Pain Scale 0(no pain to 10(worst pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Discharge (Time to hospital discharge)</measure>
    <time_frame>Same day as surgical procedure</time_frame>
    <description>Time to hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nerve Block Complications</measure>
    <time_frame>24 hours postoperatively and 2 weeks postoperatively</time_frame>
    <description>Presence/absence of nerve block complications during the first 24 hours postoperatively and 2 weeks after surgery</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">108</enrollment>
  <condition>Anesthesia</condition>
  <condition>Adductor Canal Block</condition>
  <arm_group>
    <arm_group_label>Adductor Canal Block- Injection -Site A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AC Block-Injection (lidocaine 2% and ropivacaine 1%) Site A - after the sartorius muscle crosses over the femoral artery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adductor Canal Block - Injection -Site B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AC Block-Injection (lidocaine 2% and ropivacaine 1%) Site B - before the sartorius muscle crosses over the femoral artery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adductor Canal Block -Injection -Site C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AC Block-Injection (lidocaine 2% and ropivacaine 1%) Site C - as the sartorius muscle crosses over the femoral artery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine</intervention_name>
    <description>Local anesthetic</description>
    <arm_group_label>Adductor Canal Block- Injection -Site A</arm_group_label>
    <arm_group_label>Adductor Canal Block - Injection -Site B</arm_group_label>
    <arm_group_label>Adductor Canal Block -Injection -Site C</arm_group_label>
    <other_name>Xylocaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaine</intervention_name>
    <description>Local anesthetic</description>
    <arm_group_label>Adductor Canal Block- Injection -Site A</arm_group_label>
    <arm_group_label>Adductor Canal Block - Injection -Site B</arm_group_label>
    <arm_group_label>Adductor Canal Block -Injection -Site C</arm_group_label>
    <other_name>Naropin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients booked for anterior cruciate ligament surgery under general anesthesia

          -  English speaking

          -  BMI &lt;38 kg/m2

        Exclusion Criteria:

          -  Refusal or inability to provide informed consent

          -  Allergy to local anesthetics

          -  Contraindication to regional anesthesia including coagulopathy or bleeding - diathesis

          -  Infection

          -  Nerve Injury at the site of the nerve block

          -  Malignancy at the site of the nerve block

          -  History of drug and/or alcohol dependence

          -  History of long term opioid intake or chronic pain disorder

          -  History of pre-existing neuropathy in the operative leg

          -  History of significant psychiatric conditions that may affect patient assessment

          -  Inability to understand the informed consent and demands of the study

          -  Allergy to any of the components of multi-modal analgesic regimen

          -  Revision ACL repair
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Brull, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Toronto, Women's College Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Women's College Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5S 1B2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Mariano ER, Perlas A. Adductor canal block for total knee arthroplasty: the perfect recipe or just one ingredient? Anesthesiology. 2014 Mar;120(3):530-2. doi: 10.1097/ALN.0000000000000121.</citation>
    <PMID>24534851</PMID>
  </reference>
  <reference>
    <citation>Ilfeld BM, Hadzic A. Walking the tightrope after knee surgery: optimizing postoperative analgesia while minimizing quadriceps weakness. Anesthesiology. 2013 Feb;118(2):248-50. doi: 10.1097/ALN.0b013e318279fa3a.</citation>
    <PMID>23241724</PMID>
  </reference>
  <reference>
    <citation>Hanson NA, Derby RE, Auyong DB, Salinas FV, Delucca C, Nagy R, Yu Z, Slee AE. Ultrasound-guided adductor canal block for arthroscopic medial meniscectomy: a randomized, double-blind trial. Can J Anaesth. 2013 Sep;60(9):874-80. doi: 10.1007/s12630-013-9992-9. Epub 2013 Jul 3.</citation>
    <PMID>23820968</PMID>
  </reference>
  <reference>
    <citation>Manickam B, Perlas A, Duggan E, Brull R, Chan VW, Ramlogan R. Feasibility and efficacy of ultrasound-guided block of the saphenous nerve in the adductor canal. Reg Anesth Pain Med. 2009 Nov-Dec;34(6):578-80.</citation>
    <PMID>19916251</PMID>
  </reference>
  <reference>
    <citation>Krombach J, Gray AT. Sonography for saphenous nerve block near the adductor canal. Reg Anesth Pain Med. 2007 Jul-Aug;32(4):369-70. Erratum in: Reg Anesth Pain Med. 2007 Nov-Dec;32(6):536.</citation>
    <PMID>17720129</PMID>
  </reference>
  <reference>
    <citation>Davis JJ, Bond TS, Swenson JD. Adductor canal block: more than just the saphenous nerve? Reg Anesth Pain Med. 2009 Nov-Dec;34(6):618-9. doi: 10.1097/AAP.0b013e3181bfbf00.</citation>
    <PMID>19901788</PMID>
  </reference>
  <reference>
    <citation>Jaeger P, Nielsen ZJ, Henningsen MH, Hilsted KL, Mathiesen O, Dahl JB. Adductor canal block versus femoral nerve block and quadriceps strength: a randomized, double-blind, placebo-controlled, crossover study in healthy volunteers. Anesthesiology. 2013 Feb;118(2):409-15. doi: 10.1097/ALN.0b013e318279fa0b.</citation>
    <PMID>23241723</PMID>
  </reference>
  <reference>
    <citation>Tsui BC, Ozelsel T. Ultrasound-guided transsartorial perifemoral artery approach for saphenous nerve block. Reg Anesth Pain Med. 2009 Mar-Apr;34(2):177-8; author reply 178. doi: 10.1097/AAP.0b013e31819a273e.</citation>
    <PMID>19282716</PMID>
  </reference>
  <reference>
    <citation>Jæger P, Zaric D, Fomsgaard JS, Hilsted KL, Bjerregaard J, Gyrn J, Mathiesen O, Larsen TK, Dahl JB. Adductor canal block versus femoral nerve block for analgesia after total knee arthroplasty: a randomized, double-blind study. Reg Anesth Pain Med. 2013 Nov-Dec;38(6):526-32. doi: 10.1097/AAP.0000000000000015.</citation>
    <PMID>24121608</PMID>
  </reference>
  <reference>
    <citation>Grevstad U, Mathiesen O, Valentiner LS, Jaeger P, Hilsted KL, Dahl JB. Effect of adductor canal block versus femoral nerve block on quadriceps strength, mobilization, and pain after total knee arthroplasty: a randomized, blinded study. Reg Anesth Pain Med. 2015 Jan-Feb;40(1):3-10. doi: 10.1097/AAP.0000000000000169.</citation>
    <PMID>25376972</PMID>
  </reference>
  <reference>
    <citation>Mariano ER, Kim TE, Wagner MJ, Funck N, Harrison TK, Walters T, Giori N, Woolson S, Ganaway T, Howard SK. A randomized comparison of proximal and distal ultrasound-guided adductor canal catheter insertion sites for knee arthroplasty. J Ultrasound Med. 2014 Sep;33(9):1653-62. doi: 10.7863/ultra.33.9.1653.</citation>
    <PMID>25154949</PMID>
  </reference>
  <reference>
    <citation>Bendtsen TF, Moriggl B, Chan V, Pedersen EM, Børglum J. Redefining the adductor canal block. Reg Anesth Pain Med. 2014 Sep-Oct;39(5):442-3. doi: 10.1097/AAP.0000000000000119.</citation>
    <PMID>25140514</PMID>
  </reference>
  <reference>
    <citation>Horn JL, Pitsch T, Salinas F, Benninger B. Anatomic basis to the ultrasound-guided approach for saphenous nerve blockade. Reg Anesth Pain Med. 2009 Sep-Oct;34(5):486-9. doi: 10.1097/AAP.0b013e3181ae11af.</citation>
    <PMID>19920424</PMID>
  </reference>
  <reference>
    <citation>Chi J, Chiu B, Cao Y, Liu X, Wang J, Balu N, Yuan C, Xu J. Assessment of femoral artery atherosclerosis at the adductor canal using 3D black-blood MRI. Clin Radiol. 2013 Apr;68(4):e213-21. doi: 10.1016/j.crad.2012.12.002. Epub 2013 Jan 17.</citation>
    <PMID>23332436</PMID>
  </reference>
  <reference>
    <citation>Andersen HL, Andersen SL, Tranum-Jensen J. The spread of injectate during saphenous nerve block at the adductor canal: a cadaver study. Acta Anaesthesiol Scand. 2015 Feb;59(2):238-45. doi: 10.1111/aas.12451. Epub 2014 Dec 14.</citation>
    <PMID>25496028</PMID>
  </reference>
  <reference>
    <citation>Kapoor R, Adhikary SD, Siefring C, McQuillan PM. The saphenous nerve and its relationship to the nerve to the vastus medialis in and around the adductor canal: an anatomical study. Acta Anaesthesiol Scand. 2012 Mar;56(3):365-7. doi: 10.1111/j.1399-6576.2011.02645.x.</citation>
    <PMID>22335278</PMID>
  </reference>
  <reference>
    <citation>Head SJ, Leung RC, Hackman GP, Seib R, Rondi K, Schwarz SK. Ultrasound-guided saphenous nerve block--within versus distal to the adductor canal: a proof-of-principle randomized trial. Can J Anaesth. 2015 Jan;62(1):37-44. doi: 10.1007/s12630-014-0255-1. Epub 2014 Oct 22.</citation>
    <PMID>25337966</PMID>
  </reference>
  <reference>
    <citation>Shah NA, Jain NP. Is continuous adductor canal block better than continuous femoral nerve block after total knee arthroplasty? Effect on ambulation ability, early functional recovery and pain control: a randomized controlled trial. J Arthroplasty. 2014 Nov;29(11):2224-9. doi: 10.1016/j.arth.2014.06.010. Epub 2014 Jun 19.</citation>
    <PMID>25041873</PMID>
  </reference>
  <reference>
    <citation>Saranteas T, Anagnostis G, Paraskeuopoulos T, Koulalis D, Kokkalis Z, Nakou M, Anagnostopoulou S, Kostopanagiotou G. Anatomy and clinical implications of the ultrasound-guided subsartorial saphenous nerve block. Reg Anesth Pain Med. 2011 Jul-Aug;36(4):399-402. doi: 10.1097/AAP.0b013e318220f172.</citation>
    <PMID>21697687</PMID>
  </reference>
  <reference>
    <citation>Jenstrup MT, Jæger P, Lund J, Fomsgaard JS, Bache S, Mathiesen O, Larsen TK, Dahl JB. Effects of adductor-canal-blockade on pain and ambulation after total knee arthroplasty: a randomized study. Acta Anaesthesiol Scand. 2012 Mar;56(3):357-64. doi: 10.1111/j.1399-6576.2011.02621.x. Epub 2012 Jan 4.</citation>
    <PMID>22221014</PMID>
  </reference>
  <reference>
    <citation>Espelund M, Fomsgaard JS, Haraszuk J, Mathiesen O, Dahl JB. Analgesic efficacy of ultrasound-guided adductor canal blockade after arthroscopic anterior cruciate ligament reconstruction: a randomised controlled trial. Eur J Anaesthesiol. 2013 Jul;30(7):422-8. doi: 10.1097/EJA.0b013e328360bdb9.</citation>
    <PMID>23549123</PMID>
  </reference>
  <reference>
    <citation>Kirkpatrick JD, Sites BD, Antonakakis JG. Preliminary experience with a new approach to performing an ultrasound-guided saphenous nerve block in the mid to proximal femur. Reg Anesth Pain Med. 2010 Mar-Apr;35(2):222-3. doi: 10.1097/AAP.0b013e3181d24589.</citation>
    <PMID>20216039</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2015</study_first_submitted>
  <study_first_submitted_qc>September 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2015</study_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

